JK Synapse Co Ltd
JK Synapse Co Ltd is a South Korean company engaged in the production and sale of commodity chemicals, primarily serving industrial and manufacturing sectors.
Business. JK Synapse Co Ltd (060230.KQ) is a South Korean company operating in the commodity chemicals industry within the broader chemicals sector. The firm is primarily listed on the KOSDAQ exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
JK Synapse Co Ltd (060230.KQ) is a South Korean company operating in the commodity chemicals industry within the broader chemicals sector. The firm is primarily listed on the KOSDAQ exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
JK Synapse Co Ltd operates with a market price of 404 KRW per share and a market capitalization of 19.7 billion KRW, indicating a relatively small market presence. The company's price-to-book ratio is 0.19, and its price-to-tangible-book ratio is also 0.19, suggesting that the market values the company significantly below its book value. The enterprise value to EBITDA ratio is negative at -30.01, reflecting the company's current unprofitability, while the enterprise value to revenue ratio is 7.88, indicating a moderate valuation relative to its revenue.
The company's profitability metrics are concerning, with a return on equity of -5.32% and a return on assets of -2.08%, both significantly below industry norms. These figures suggest that the company is not generating returns for its shareholders or effectively utilizing its assets. The gross profit margin is 21.73%, and the operating margin is -26.26%, further highlighting the company's operational inefficiencies and cost management issues.
Geographically, the company's revenue is concentrated in South Korea, with no significant international exposure disclosed. The company's business is primarily driven by its commodity chemicals segment, which is subject to volatile raw material prices and demand fluctuations. The lack of diversification increases the company's exposure to local economic conditions and industry-specific risks.
Looking ahead, the company's revenue is expected to remain under pressure, with no clear signs of improvement in the near term. The operating cash flow is negative at -3.13 billion KRW, and the free cash flow is also negative at -2.88 billion KRW, indicating that the company is not generating sufficient cash to fund its operations or invest in growth. The capital expenditure of -300.98 million KRW suggests minimal investment in new projects or capacity expansion.
The company's risk profile is elevated, with a medium liquidity risk and a low dilution risk. The key financial flag is the negative net cash position after subtracting total debt, which indicates that the company's cash reserves are insufficient to cover its long-term obligations. The debt-to-equity ratio of 0.78 suggests a moderate level of leverage, but the negative operating and free cash flows increase the risk of default.
Recent filings and transcripts indicate that the company is facing challenges in managing its costs and improving its operational efficiency. The negative net income of -5.41 billion KRW and the operating loss of -3.07 billion KRW highlight the urgency of addressing these issues. The company's management has not disclosed any significant strategic initiatives or cost-cutting measures that could reverse the current trend.
- The company is trading at a significant discount to its book value, with a price-to-book ratio of 0.19.
- Profitability metrics are negative, with a return on equity of -5.32% and a return on assets of -2.08%.
- The company's revenue is concentrated in South Korea, with no significant international exposure.
- Operating and free cash flows are negative, indicating a lack of cash generation and potential liquidity issues.
- The company's debt-to-equity ratio is 0.78, and it has a negative net cash position after subtracting total debt.
Bull / Bear case
Generated · model-assistedRevenue grew 26.8% year-over-year to 61.9 billion KRW, demonstrating strong top-line expansion momentum.
Net income improved significantly by 68.1% year-over-year, indicating a substantial reduction in net losses.
Operating income surged 77.8% year-over-year, reflecting improved core operational efficiency and cost management.
Free cash flow improved by 66.4% year-over-year, suggesting better cash generation capabilities despite negative balances.
The company maintains a 20.5% four-year revenue CAGR, showing consistent long-term growth trajectory.
The company faces high credit risk, signaling potential difficulties in meeting financial obligations or debt servicing.
Debt-to-equity ratio of 0.78 is in the bottom quartile, implying higher leverage risk than most peers.
Return on equity of -5.32% falls in the bottom quartile, showing poor capital efficiency compared to peers.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- JK Synapse Co Ltd Market data — financials · 2026-05-26